These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31263214)

  • 21. An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    J Trace Elem Med Biol; 2010 Jan; 24(1):42-5. PubMed ID: 20122579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2
    Gibson RA; Lim JA; Choi SJ; Flores L; Clinton L; Bali D; Young S; Asokan A; Sun B; Kishnani PS
    Mol Genet Metab; 2021 Jul; 133(3):269-276. PubMed ID: 34083142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX.
    Cabrera-Abreu J; Crabtree NJ; Elias E; Fraser W; Cramb R; Alger S
    J Inherit Metab Dis; 2004; 27(1):1-9. PubMed ID: 14970741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker.
    Paesold-Burda P; Baumgartner MR; Santer R; Bosshard NU; Steinmann B
    J Inherit Metab Dis; 2007 Nov; 30(6):896-902. PubMed ID: 17994282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial Effects of Modified Atkins Diet in Glycogen Storage Disease Type IIIa.
    Olgac A; İnci A; Okur İ; Biberoğlu G; Oğuz D; Ezgü FS; Kasapkara ÇS; Aktaş E; Tümer L
    Ann Nutr Metab; 2020; 76(4):233-241. PubMed ID: 32712609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen storage disease type III in Egyptian children: a single centre clinico-laboratory study.
    El-Karaksy H; Anwar G; El-Raziky M; Mogahed E; Fateen E; Gouda A; El-Mougy F; El-Hennawy A
    Arab J Gastroenterol; 2014 Jun; 15(2):63-7. PubMed ID: 25097048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases.
    Sluiter W; van den Bosch JC; Goudriaan DA; van Gelder CM; de Vries JM; Huijmans JG; Reuser AJ; van der Ploeg AT; Ruijter GJ
    Clin Chem; 2012 Jul; 58(7):1139-47. PubMed ID: 22623745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history study of hepatic glycogen storage disease type IV and comparison to Gbe1ys/ys model.
    Koch RL; Kiely BT; Choi SJ; Jeck WR; Flores LS; Sood V; Alam S; Porta G; LaVecchio K; Soler-Alfonso C; Kishnani PS
    JCI Insight; 2024 May; 9(12):. PubMed ID: 38912588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic glycogen storage disorders: what have we learned in recent years?
    Burda P; Hochuli M
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse model of glycogen storage disease type III.
    Liu KM; Wu JY; Chen YT
    Mol Genet Metab; 2014 Apr; 111(4):467-76. PubMed ID: 24613482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bulbar muscle weakness and fatty lingual infiltration in glycogen storage disorder type IIIa.
    Horvath JJ; Austin SL; Jones HN; Drake EJ; Case LE; Soher BJ; Bashir MR; Kishnani PS
    Mol Genet Metab; 2012 Nov; 107(3):496-500. PubMed ID: 23062577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mitochondrial dysfunction in children with hepatic forms of glycogen storage disease].
    Kurbatova OV; Izmaĭlova TD; Surkov AN; Namazova-Baranova LS; Poliakova SI; Miroshkina LV; Semenova GF; Samokhina IV; Kapustina EIu; Dukhova ZN; Potapov AS; Petrichuk SV
    Vestn Ross Akad Med Nauk; 2014; (7-8):78-84. PubMed ID: 25563007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.
    Roscher A; Patel J; Hewson S; Nagy L; Feigenbaum A; Kronick J; Raiman J; Schulze A; Siriwardena K; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2014 Nov; 113(3):171-6. PubMed ID: 25266922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glomerular and tubular function in glycogen storage disease.
    Lee PJ; Dalton RN; Shah V; Hindmarsh PC; Leonard JV
    Pediatr Nephrol; 1995 Dec; 9(6):705-10. PubMed ID: 8747109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel variants in Turkish patients with glycogen storage disease.
    Çakar NE; Gezdirici A; Topuz HŞ; Önal H
    Pediatr Int; 2020 Oct; 62(10):1145-1150. PubMed ID: 32374048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III.
    Yekeler E; Dursun M; Emeksiz E; Akkoyunlu M; Akyol Y; Demir F; Gökcay G; Demirkol M
    Turk J Pediatr; 2007; 49(2):115-9. PubMed ID: 17907509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of cornstarch therapy in type III glycogen-storage disease.
    Gremse DA; Bucuvalas JC; Balistreri WF
    Am J Clin Nutr; 1990 Oct; 52(4):671-4. PubMed ID: 2403059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases.
    Pursell N; Gierut J; Zhou W; Dills M; Diwanji R; Gjorgjieva M; Saxena U; Yang JS; Shah A; Venkat N; Storr R; Kim B; Wang W; Abrams M; Raffin M; Mithieux G; Rajas F; Dudek H; Brown BD; Lai C
    Mol Ther; 2018 Jul; 26(7):1771-1782. PubMed ID: 29784585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability of histological criteria in glycogen storage disease of the liver.
    Jevon GP; Finegold MJ
    Pediatr Pathol; 1994; 14(4):709-21. PubMed ID: 7971588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.